Bioavailability in Patient With Psoriasis: Metoject Prefilled Pen

Summary

This study is conducted to assess the relative bioavailability of MTX administered subcutaneously via a prefilled pen (50mg/mL) compared with MTX administered via IM injection (25mg/mL).

Timeline

Start

2013-05

Primary completion

2013-10

Completion

—

Drugs

Indications